Frank I Choi
Examiner (ID: 4140, Phone: (571)272-0610 , Office: P/1616 )
Most Active Art Unit | 1616 |
Art Unit(s) | 1616 |
Total Applications | 1154 |
Issued Applications | 390 |
Pending Applications | 117 |
Abandoned Applications | 646 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16343961
[patent_doc_number] => 20200308611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => CARBON DIOXIDE BIOCONVERSION PROCESS
[patent_app_type] => utility
[patent_app_number] => 16/530481
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/530481 | Carbon dioxide bioconversion process | Aug 1, 2019 | Issued |
Array
(
[id] => 18748592
[patent_doc_number] => 11807891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Carbon monoxide and carbon dioxide bioconversion process
[patent_app_type] => utility
[patent_app_number] => 16/530502
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11241
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/530502 | Carbon monoxide and carbon dioxide bioconversion process | Aug 1, 2019 | Issued |
Array
(
[id] => 17168854
[patent_doc_number] => 20210322524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISRODERS
[patent_app_type] => utility
[patent_app_number] => 17/264923
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264923 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISRODERS | Jul 30, 2019 | Pending |
Array
(
[id] => 16252145
[patent_doc_number] => 20200261519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => COMPOSITE PROBIOTICS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/520366
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16520366
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/520366 | Composite probiotics and use thereof | Jul 23, 2019 | Issued |
Array
(
[id] => 17576827
[patent_doc_number] => 20220133682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => SOLUBILIZATE WITH CURCUMIN AND AT LEAST THE CANNABINOID THC AS A FURTHER ACTIVE SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 17/258397
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258397
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/258397 | SOLUBILIZATE WITH CURCUMIN AND AT LEAST THE CANNABINOID THC AS A FURTHER ACTIVE SUBSTANCE | Jul 9, 2019 | Pending |
Array
(
[id] => 15326861
[patent_doc_number] => 20200003760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => IN-VITRO METHODS FOR CLASSIFYING DRUGS ACCORDING TO THEIR POTENTIAL TO CAUSE LIVER CELL INJURY
[patent_app_type] => utility
[patent_app_number] => 16/456972
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/456972 | IN-VITRO METHODS FOR CLASSIFYING DRUGS ACCORDING TO THEIR POTENTIAL TO CAUSE LIVER CELL INJURY | Jun 27, 2019 | Abandoned |
Array
(
[id] => 16978991
[patent_doc_number] => 20210223228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => BLEOMYCIN FOR MIMICKING THE EFFECT OF IONIZING RADIATIONS ON T CELLS
[patent_app_type] => utility
[patent_app_number] => 15/734327
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734327
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734327 | Bleomycin for mimicking the effect of ionizing radiations on T cells | Jun 6, 2019 | Issued |
Array
(
[id] => 16948390
[patent_doc_number] => 20210207081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/059965
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059965 | MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF | May 30, 2019 | Pending |
Array
(
[id] => 15175365
[patent_doc_number] => 20190358274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 16/422311
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422311 | METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS | May 23, 2019 | Abandoned |
Array
(
[id] => 14833443
[patent_doc_number] => 20190275122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN
[patent_app_type] => utility
[patent_app_number] => 16/421068
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16421068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/421068 | PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN | May 22, 2019 | Abandoned |
Array
(
[id] => 16822750
[patent_doc_number] => 20210138043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => COMPOUNDS AND METHODS FOR THE IMMOBILIZATION OF MYOSTATIN-INHIBITORS ON THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE
[patent_app_type] => utility
[patent_app_number] => 17/047851
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047851 | COMPOUNDS AND METHODS FOR THE IMMOBILIZATION OF MYOSTATIN-INHIBITORS ON THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE | May 16, 2019 | Pending |
Array
(
[id] => 17068600
[patent_doc_number] => 20210270815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => SPERM FERTILITY CAPACITY TEST AND SPERM DECAPACITATING SUPPLEMENT
[patent_app_type] => utility
[patent_app_number] => 17/056446
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056446 | SPERM FERTILITY CAPACITY TEST AND SPERM DECAPACITATING SUPPLEMENT | May 16, 2019 | Pending |
Array
(
[id] => 16221733
[patent_doc_number] => 20200246849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => A METHOD FOR REMEDIATION OF CONTAMINATED LANDS
[patent_app_type] => utility
[patent_app_number] => 16/637283
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637283 | Method for remediation of contaminated lands | May 15, 2019 | Issued |
Array
(
[id] => 17415125
[patent_doc_number] => 20220050029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => ELECTROPHORETIC BIOLOGICAL SAMPLE STAINING METHOD AND STAINING APPARATUS USING
[patent_app_type] => utility
[patent_app_number] => 17/056451
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056451 | ELECTROPHORETIC BIOLOGICAL SAMPLE STAINING METHOD AND STAINING APPARATUS USING | May 8, 2019 | Pending |
Array
(
[id] => 14864777
[patent_doc_number] => 20190282630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/285088
[patent_app_country] => US
[patent_app_date] => 2019-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285088 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | May 6, 2019 | Abandoned |
Array
(
[id] => 14743819
[patent_doc_number] => 20190255083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => USE OF PURIFIED 2'-FUCOSYLLACTOSE, 3-FUCOSYLLACTOSE AND LACTODIFUCOTETRAOSE AS PREBIOTICS
[patent_app_type] => utility
[patent_app_number] => 16/403095
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16403095
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/403095 | USE OF PURIFIED 2'-FUCOSYLLACTOSE, 3-FUCOSYLLACTOSE AND LACTODIFUCOTETRAOSE AS PREBIOTICS | May 2, 2019 | Pending |
Array
(
[id] => 15834777
[patent_doc_number] => 20200132670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE
[patent_app_type] => utility
[patent_app_number] => 16/393684
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393684
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393684 | FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE | Apr 23, 2019 | Abandoned |
Array
(
[id] => 14990861
[patent_doc_number] => 20190314388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING DEOXYCHOLIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/384703
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384703
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/384703 | PHARMACEUTICAL COMPOSITION CONTAINING DEOXYCHOLIC ACID | Apr 14, 2019 | Abandoned |
Array
(
[id] => 14649605
[patent_doc_number] => 20190231931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => METHODS OF REMOVING ALPHA-GALACTOSE
[patent_app_type] => utility
[patent_app_number] => 16/379276
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379276 | METHODS OF REMOVING ALPHA-GALACTOSE | Apr 8, 2019 | Abandoned |
Array
(
[id] => 14649601
[patent_doc_number] => 20190231929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => METHOD FOR PREPARING CORNEAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 16/377041
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377041
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377041 | METHOD FOR PREPARING CORNEAL TISSUE | Apr 4, 2019 | Abandoned |